Form IV of the calcium channel blocker, Felodipine was obtained consistently via solvent evaporation in a pH-controlled solution, and followed by large-scale crystallization through seeding the saturated solution of Felodipine. Comparing with form I, the crystal form used in the marketed products, form IV has higher melting temperature but lower melting enthalpy. Hence, according to the heat of fusion rule, polymorphs I and IV should be in an enantiotropic relationship. Form I is thermodynamically more stable than form IV at room temperature. Their theoretical polymorphic transformation temperature was estimated at 87.6 A degrees C, which was also confirmed by the solvent-mediated polymorphic transformation experiments
Pridopidine hydrochloride (Huntexil, NeuroSearch A/S, Ballerup, Denmark) is a dopaminergic stabilize...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
The pressure-temperature phase diagram of the dimorphism of racemic m-nisoldipine is constructed usi...
Solvates of the calcium-channel blocking agent felodipine with three structurally related common org...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
Azelnidipine, a new dihydropyridine calcium ion antagonist, was protected by patent in Japan. In pre...
To improve the dissolution and hence the oral bioavailability, amorphous felodipine (FEL) solid disp...
International audienceThe crystal structures of dimorphic benzylthiouracil, a drug against hyperthyr...
ABSTRACT: Famotidine crystallizes in two different polymorphic forms: the metastable polymorph B and...
The amorphous → metastable and metastable → stable crystalline phase transitions of nifedipine and t...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Pridopidine hydrochloride (Huntexil, NeuroSearch A/S, Ballerup, Denmark) is a dopaminergic stabilize...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
The pressure-temperature phase diagram of the dimorphism of racemic m-nisoldipine is constructed usi...
Solvates of the calcium-channel blocking agent felodipine with three structurally related common org...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
Azelnidipine, a new dihydropyridine calcium ion antagonist, was protected by patent in Japan. In pre...
To improve the dissolution and hence the oral bioavailability, amorphous felodipine (FEL) solid disp...
International audienceThe crystal structures of dimorphic benzylthiouracil, a drug against hyperthyr...
ABSTRACT: Famotidine crystallizes in two different polymorphic forms: the metastable polymorph B and...
The amorphous → metastable and metastable → stable crystalline phase transitions of nifedipine and t...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Pridopidine hydrochloride (Huntexil, NeuroSearch A/S, Ballerup, Denmark) is a dopaminergic stabilize...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...
Donepezil is used for the palliative treatment of mild to moderate dementia of the Alzheimer’s disea...